The formation of CRC involves multiple pathways and stepwise genetic changes; several biomarkers (APC, p53, KRAS, and BRAF) are used to detect CRC, but these biomarkers are not sufficiently sensitive and specific. The gene discussed is BRAF; the disease is colorectal carcinoma.